Biomarin Pharmaceutical (BMRN) Other Accumulated Expenses (2010 - 2019)
Biomarin Pharmaceutical (BMRN) reported Other Accumulated Expenses of $46.11 million for Q1 2019, up 19.9% from $38.45 million a year earlier and up 6.9% from the prior quarter.
Biomarin Pharmaceutical (BMRN) Other Accumulated Expenses (2010 - 2019) Analysis & Trends
At the end of FY2018, Biomarin Pharmaceutical posted Other Accumulated Expenses of $43.12 million, up 18.2% from FY2017.
- Other Accumulated Expenses has increased for eight consecutive years, with a five-year compound annual growth rate of 32.8% (FY2013 to FY2018).
- By year, Other Accumulated Expenses came in at $36.47 million in FY2017 (+5.0%), $34.74 million in FY2016 (+6.7%), $32.55 million in FY2015 (+119.1%) and $14.86 million in FY2014 (+42.5%).
- Five-year quarterly Other Accumulated Expenses spans a low of $11.98 million in Q2 2014 and a high of $50.94 million in Q2 2018.
- Year over year, Other Accumulated Expenses has now increased in each of the last 14 quarters, with growth averaging 15.3% over the last eight quarters.
- Over the past five years, the year-over-year growth in Other Accumulated Expenses ranged from 5.0% (Q4 2017) to 146.1% (Q2 2015).
- Per Business Quant data, the three quarters before Q1 2019 came in at $43.12 million (Q4 2018), $42.35 million (Q3 2018) and $50.94 million (Q2 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Biomarin Pharmaceutical | 11.07 Bn | 4.93 Bn | 786.91 Mn |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | 46.11 Mn |
| Dec 31, 2018 | 43.12 Mn |
| Sep 30, 2018 | 42.35 Mn |
| Jun 30, 2018 | 50.94 Mn |
| Mar 31, 2018 | 38.45 Mn |
| Dec 31, 2017 | 36.47 Mn |
| Sep 30, 2017 | 38.32 Mn |
| Jun 30, 2017 | 37.97 Mn |
| Mar 31, 2017 | 36.16 Mn |
| Dec 31, 2016 | 34.74 Mn |
| Sep 30, 2016 | 34.18 Mn |
| Jun 30, 2016 | 32.64 Mn |
| Mar 31, 2016 | 34.16 Mn |
| Dec 31, 2015 | 32.55 Mn |
| Sep 30, 2015 | 27.36 Mn |
| Jun 30, 2015 | 29.49 Mn |
| Mar 31, 2015 | 17.17 Mn |
| Dec 31, 2014 | 14.86 Mn |
| Jun 30, 2014 | 11.98 Mn |
| Mar 31, 2014 | 10.76 Mn |
Biomarin Pharmaceutical Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BMRN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();